{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:12:11Z","timestamp":1768345931298,"version":"3.49.0"},"reference-count":18,"publisher":"SLACK, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Refract Surg"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To compare the efficacy of topical nepafenac alone versus nepafenac combined with cyclopentolate for pain management after photorefractive keratectomy (PRK) through a comprehensive evaluation of pain intensity, stinging, tearing, light sensitivity, analgesic use, and sleep disturbance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a retrospective comparative study using data from a randomized controlled trial registry. A total of 160 patients undergoing PRK were analyzed. Patients were randomized to receive a standard nepafenac regimen either alone or with the addition of perioperative cyclopentolate 1%. Pain, stinging, tearing, and light sensitivity were rated on a visual analog scale (0 to 10) twice daily for 5 postoperative days. Sleep disturbance and analgesic use were also recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The nepafenac-only group reported significantly lower pain score means over the 5 days compared to the nepafenac + cyclopentolate group (3.48 \u00b1 2.25 vs 5.42 \u00b1 3.20,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Secondary outcomes also favored the nepafenac-only group with lower reported levels of stinging sensation (1.72 \u00b1 1.88 vs 5.86 \u00b1 3.36,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), tearing (4.43 \u00b1 3.32 vs 5.45 \u00b1 3.60,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001), and light sensitivity (3.75 \u00b1 3.32 vs. 4.47 \u00b1 3.60,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). Moreover, sleep disturbance was less frequent in the nepafenac-only group during the first two postoperative nights (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Contrary to theoretical expectations, adding cyclopentolate to nepafenac therapy worsened postoperative pain outcomes after PRK. For optimal pain management, a regimen of nepafenac alone appears superior to the combination therapy approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3928\/1081597x-20251202-01","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:25:02Z","timestamp":1768235102000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Topical Nepafenac Versus Nepafenac With Perioperative Cyclopentolate for Pain Management After Photorefractive Keratectomy: A Comparative Clinical Evaluation"],"prefix":"10.3928","volume":"42","author":[{"given":"Ben","family":"Klinghoffer","sequence":"first","affiliation":[{"name":"Enaim Refractive Surgery Centers, Tel Avivi, Israel;"},{"name":"Department of Ophthalmology, Rambam Health Care Campus Affiliated with the Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asaf","family":"Achiron","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tel Aviv Sourasky Medical Center and School of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elad","family":"Eilon","sequence":"additional","affiliation":[{"name":"Enaim Refractive Surgery Centers, Tel Avivi, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira","family":"Citron","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tel Aviv Sourasky Medical Center and School of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliya","family":"Levinger","sequence":"additional","affiliation":[{"name":"Enaim Refractive Surgery Centers, Tel Avivi, Israel;"},{"name":"Department of Ophthalmology, Tel Aviv Sourasky Medical Center and School of Medicine, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedinformatics2040046"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S86812"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000271"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20080401-11"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02849978"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-024-01040-8"},{"issue":"2","key":"e_1_3_2_8_2","first-page":"255","article-title":"Iritis. How to recognize and manage a potentially sight-threatening disease","volume":"99","author":"Nishimoto JY","year":"1996","unstructured":"Nishimoto JY. Iritis. How to recognize and manage a potentially sight-threatening disease. Postgrad Med. 1996;99(2):255\u2013257, 261\u2013262. PMID:8632971","journal-title":"Postgrad Med"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.4103\/DJO.DJO_40_19"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S388982"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/opo.12773"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.247421"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007049015148"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2012.07.003"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2015.11.006"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2016.0057"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.08.007"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-01941-3"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.04.004"}],"container-title":["Journal of Refractive Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T16:25:15Z","timestamp":1768235115000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/1081597X-20251202-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.3928\/1081597X-20251202-01"],"URL":"https:\/\/doi.org\/10.3928\/1081597x-20251202-01","relation":{},"ISSN":["1081-597X"],"issn-type":[{"value":"1081-597X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}